Skip to content
← Back to this collection

PUBLICATIONS · 15494430

CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2005 Feb 15
First author
Marcus R

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Marcus R
      type
      Author
    2. name
      Imrie K
      type
      Author
    3. name
      Belch A
      type
      Author
    4. name
      Cunningham D
      type
      Author
    5. name
      Flores E
      type
      Author
    6. name
      Catalano J
      type
      Author
    7. name
      Solal-Celigny P
      type
      Author
    8. name
      Offner F
      type
      Author
    9. name
      Walewski J
      type
      Author
    10. name
      Raposo J
      type
      Author
    11. name
      Jack A
      type
      Author
    12. name
      Smith P
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Marcus R
      type
      Author
    2. name
      Imrie K
      type
      Author
    3. name
      Belch A
      type
      Author
    4. name
      Cunningham D
      type
      Author
    5. name
      Flores E
      type
      Author
    6. name
      Catalano J
      type
      Author
    7. name
      Solal-Celigny P
      type
      Author
    8. name
      Offner F
      type
      Author
    9. name
      Walewski J
      type
      Author
    10. name
      Raposo J
      type
      Author
    11. name
      Jack A
      type
      Author
    12. name
      Smith P
      type
      Author
    bibliography ids
    1. nci-bib-a8b4faa0a45f3ad2fa9a6155
    book metadata
    content sha256
    2e8e5843c1e2a9049a5000b090da491456a151a5f9cb37632af1c6da481ec0ba
    document type
    citation
    dois
    1. 10.1182/blood-2004-08-3175
    electronic publication date
    display
    2004 Oct 19
    precision
    day
    year
    2004
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:15494430
    immutable id
    pubmed:15494430@2e8e5843c1e2a9049a5000b090da491456a151a5f9cb37632af1c6da481ec0ba
    journal
    abbreviation
    Blood
    issn electronic
    Source null
    issn print
    0006-4971
    issue
    4
    name
    Blood
    nlm unique id
    7603509
    pages
    1417-23
    volume
    105
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      15494430
      provenance
      batch id
      97b9e848a139d5f8d462
      provider
      NCBI PubMed ESummary
      record sha256
      f3386b2ecd227dfc28a2cc7102998ccc48ddcdd7b3bb443e790721b91ac2066f
      response sha256
      a316b1e9f1b120fc4a41adaaf2b205cc00afcf76d9a093a7cfa9ed2743d05be8
      retrieved at
      2026-09-09T23:45:57.930512+00:00
      publication date
      display
      2005 Feb 15
      precision
      day
      year
      2005
      publication types
      1. Clinical Trial
      2. Comparative Study
      3. Journal Article
      4. Multicenter Study
      5. Randomized Controlled Trial
      6. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/15494430/
      title
      CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma.

      Preserved source evidence · Independent clinical review pending · Not medical advice